Literature DB >> 10192765

Oxidative inactivation of surfactants.

S Andersson1, A Kheiter, T A Merritt.   

Abstract

Reactive oxygen species (ROS) may play an important role in the chronic pulmonary morbidity of preterm infants. We therefore studied the magnitude and mechanisms of oxidative inactivation of a natural lung surfactant (NLS) and of two surfactants used for treatment of respiratory distress syndrome, beractant and KL4 surfactant (KL4). Incubation with Fenton reagents, 2-4 mM peroxynitrite (ONOO-) or 0.5 mM hypochlorous acid (OCl-), resulted in an increased minimum surface tension (MST) of all surfactants; the order of effect on MST was beractant > KL4 > NLS. After incubation with Fenton reagents, NLS contained a higher concentration of conjugated dienes (p < 0.01) but lower concentration of malondialdehyde (p < 0.001) than beractant. Protein carbonyl concentrations after treatment with Fenton reagents were higher in NLS and KL4 than in beractant (p < 0. 05). Surface area cycling for 24 h with 2 mM ONOO- or 0.5 mM OCl- caused both beractant and KL4 to increase the proportion of light subtypes from 8-10% to 26-29%; with Fenton reagents, there was disappearance of the light subtype and formation of ultraheavy subtype 74-91% with poor MST. Natural and therapeutic surfactants differ markedly in their sensitivity to ROS, which may be important for surfactants in therapeutic use because oxidative inactivation may limit their effect. Oxidation of natural surfactant may result in reduced function and contribute to chronic lung disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192765     DOI: 10.1007/pl00007639

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  15 in total

1.  An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film.

Authors:  Zoya Leonenko; Simardeep Gill; Svetlana Baoukina; Luca Monticelli; Jana Doehner; Lasantha Gunasekara; Florian Felderer; Mathias Rodenstein; Lukas M Eng; Matthias Amrein
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

2.  Lucinactant: new and approved, but is it an improvement?

Authors:  Sandra S Garner; Toby H Cox
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

3.  Radiation Mitigating Properties of Intranasally Administered KL4 Surfactant in a Murine Model of Radiation-Induced Lung Damage.

Authors:  Melpo Christofidou-Solomidou; Ralph A Pietrofesa; Evguenia Arguiri; Constantinos Koumenis; Robert Segal
Journal:  Radiat Res       Date:  2017-09-06       Impact factor: 2.841

4.  Lung surfactant gelation induced by epithelial cells exposed to air pollution or oxidative stress.

Authors:  Jay W Anseth; An J Goffin; Gerald G Fuller; Andrew J Ghio; Peter N Kao; Daya Upadhyay
Journal:  Am J Respir Cell Mol Biol       Date:  2005-04-28       Impact factor: 6.914

5.  Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C.

Authors:  Karina Rodríguez-Capote; Dahis Manzanares; Thomas Haines; Fred Possmayer
Journal:  Biophys J       Date:  2006-01-27       Impact factor: 4.033

6.  Targeted Disruption of Ig-Hepta/Gpr116 Causes Emphysema-like Symptoms That Are Associated with Alveolar Macrophage Activation.

Authors:  Donna Maretta Ariestanti; Hikaru Ando; Shigehisa Hirose; Nobuhiro Nakamura
Journal:  J Biol Chem       Date:  2015-03-16       Impact factor: 5.157

7.  A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.

Authors:  Carlos G Guardia; Fernando R Moya; Sunil Sinha; Phillip D Simmons; Robert Segal; Jay S Greenspan
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

Review 8.  An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease.

Authors:  Paul O Nkadi; T Allen Merritt; De-Ann M Pillers
Journal:  Mol Genet Metab       Date:  2009-02-04       Impact factor: 4.797

9.  Maternal loading with very low-density lipoproteins stimulates fetal surfactant synthesis.

Authors:  Alan J Ryan; Jheem D Medh; Diann M McCoy; Ronald G Salome; Rama K Mallampalli
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

10.  Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins.

Authors:  Mustafa Al-Saiedy; Lasantha Gunasekara; Francis Green; Ryan Pratt; Andrea Chiu; Ailian Yang; John Dennis; Cora Pieron; Candice Bjornson; Brent Winston; Matthias Amrein
Journal:  Mil Med       Date:  2018-03-01       Impact factor: 1.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.